Omicron Now Has Three Sub-Variants, Say Experts

HYDERABAD : The variant of concern, Omicron, has now three siblings – one up from two sub-lineages discovered last week.

According to Phylogenetic Assignment of Named Global Outbreak Lineages (PANGOLIN) that assigns lineages under ‘Pango lineage’ system to various viruses including the novel coronavirus that causes Covid-19, the third outlier of Omicron was found from a sample collected from England on December 3. The new outlier of Omicron variant is temporarily named England/MILK-2D24AC9/2021.

Dr Vinod Scaria of Institute of Genomics and Integrative Biology (IGIB), New Delhi, confirmed the development by tweeting late on Sunday about the new outlier of Omicron lineage with some shared mutations.

Omicron variant or B.1.1.529 split into two sub-lineages BA.1 and BA.2 earlier this month. These two variants have some shared mutations, besides some mutations that are unique to them. “A new diverse genome has appeared within the B.1.1.529 lineage that has all of the shared mutations of B.1.1.529, some of the mutations unique to BA.1 and some unique to BA.2 plus a few of its own,” PANGOLIN announced in its website.

It added it seems likely the new Omicron outlier is an additional circulating member of B.1.1.529 diversity and recombination has occurred in its history. It also said it “may have mutated prior to emergence of BA.1 clade based on pattern of mutations.” It said, “as a single genome it doesn’t yet require a lineage designation and at the moment it will be classified as a member of Omicron”. Experts say though Omicron has been spreading faster than previous variants, most cases are mild.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 15 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 46 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt